Acurx Pharmaceuticals, Inc. (ACXP)
2.65
-0.04
(-1.49%)
USD |
NASDAQ |
Jan 16, 16:00
2.64
-0.01
(-0.38%)
After-Hours: 20:00
Acurx Pharmaceuticals EPS Diluted (Quarterly): -1.226 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Adial Pharmaceuticals, Inc. | -0.0809 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.993M |
| Total Expenses (Quarterly) | 1.993M |
| Enterprise Value | -1.831M |
| Earnings Yield | -244.8% |
| Normalized Earnings Yield | -244.79 |